The Future Of Nano Technology
- Alan Watts
- Anti-Aging Medicine
- David Sinclair
- Gene Medicine
- Gene therapy
- Genetic Medicine
- Genetic Therapy
- Hormone Replacement Therapy
- Human Genetic Engineering
- Human Reproduction
- Integrative Medicine
- Life Skills
- Longevity Medicine
- Machine Learning
- Medical School
- Nano Medicine
- Parkinson's disease
- Quantum Computing
- Regenerative Medicine
- Stem Cell Therapy
- Stem Cells
- Biogen boosts gene therapy strategy with Harvard pact focused on inherited eye disease – FierceBiotech
- Hansa Biopharma Gets up to 350M to Make Gene Therapy Work in Resistant… – Labiotech.eu
- FDA Grants Orphan Drug Designation to Neurogene’s Gene Therapy for the Treatment of CLN5 Batten Disease – BioSpace
- Tiny mineral particles are better vehicles for promising gene therapy – ScienceBlog.com
- The Wilderness of Rare Genetic Diseases and the Parents Navigating It – The New York Times
- avast warning for phishing
- the concept of race has no genetic or scientific basis” and that “race is a social concept not a scientific one” (Witt 2010)
- Nanomedicine-Nanotechnology Biology and Medicine
- what happened to jackson avery on greys
- broadcast schedule
- greys anatomy jackson child
- harris silver md
- heroes season 1 claires immortality
- pros and cons of human activity on plants and animals
- higher ed mcat
|Search Immortality Topics:|
Category Archives: Biochemistry
Chemists, biochemists and physicists at Bristol, Exeter and Sheffield have teamed up in a 7.25 million five-year project that could drive down the cost of energy production and help in the governments net zero carbon ambitions
The Engineering and Physical Sciences Research Council (EPSRC) has awarded funding for a programme designed to develop 'Molecular Photonic Breadboards'. These are organic molecular materials that it is hoped will enable highly efficient capture and transport of light energy.
Solar cells are powered by silicon semiconductors absorbing sunlight and converting that light into electricity. For organic materials to match the efficiency of silicon, scientists need to control the behaviour of excitons - formed when light is absorbed by molecules - much more effectively.
The project, led by Professor Graham Leggett, a chemist at the University of Sheffield. Professor Leggett said: "Control of excitons is essential for many new and emerging technologies identified in the government's Industrial Strategy as being vital to the economic success of the UK, including solar energy capture, photocatalysis, quantum technologies, and the design of diagnostic devices for personalised medicine.
"An unsolved grand challenge has been to develop design rules for the long-range transport of excitons. Our goal is to solve this grand challenge."
Bristols involvement centres on the Bristol BioDesign Institute and Professor Dek Woolfson's protein-design laboratory. Dek, who is Professor of Chemistry and Biochemistry, commented: "This is a really exciting project. For several years, we have been designing proteins from scratch mostly just to see if it could be done. This led to the discovery of a completely new class of proteins that we call alpha-helical barrels. Their unusual shapes make them ideal for applications of the type that will be explored in this collaboration with Graham and colleagues."
The 7.25 million grant includes 800,000 for the protein-design work at Bristol.
About Bristol BioDesign InstituteBristol BioDesign Institute (BBI)is the University of Bristol's Specialist Research Institute for synthetic biology. With wide-ranging applications from health to food security, BBI combines pioneering synthetic biology approaches with understanding biomolecular systems to deliver the rational design and engineering of biological systems for useful purposes.
This is delivered through multidisciplinary research that brings together postgraduate and postdoctoral researchers, academics, policy makers and industry, whilst also engaging the public with emerging solutions to global challenges.
See original here:
June: epsrc-zerocarbon | News and features - University of Bristol
She has mentored young students with English as a second language and helped steer a committee dedicated to helping vulnerable women gain access to education.
Lakhani was born inUganda andhas an honours degree in clinical biochemistry from the University of Manchester.
She has been in Edmonton for more than 40 years, owning and operating an early childhood education centre.
In 2005, she was awarded the Alberta Centennial Medal for outstanding achievementsin the province. And in2012, she was awarded the Queen Elizabeth Diamond Jubilee Medal honouring service to Canada.
Lieutenant-governors,the highest-ranking officers in each province, carry out a variety of official dutiesincludingswearing in the premier and cabinet, opening each session of the legislative assembly and signing bills into laws.
Ms. Lakhani is devoted to supporting people in her community, from new immigrants and young people, to women and families, Trudeau said in a news release Tuesday.
As lieutenant governor of Alberta, I know she will serve the people of her province and our country well, and continue to be a source of inspiration for all Canadians.
This report by The Canadian Press was first published June 30, 2020
The Canadian Press
PUBLISHED: 10:00 29 June 2020
Dr Winston Morgan, Reader in Toxicology and Clinical Biochemistry at the University of East London, says race and genetics are key omissions from the PHE report on coronavirus. Picture: University of East London
Email this article to a friend
To send a link to this page you must be logged in.
Dr Morgan a reader in toxicology and clinical biochemistry at the university commended the report for properly addressing the structural problems linked to racism which have caused Covid-19 to disproportionately impact BAME communities.
However, the lecturer criticised the complete lack of consideration given to the issue of genetics, and specifically to answering the question as to whether certain traits increase virus susceptibility.
Failing to adequately address this subject leaves the door open for continued speculation around race and genetics, said Dr Morgan.
This report was an opportunity to knock the speculation on its head, and allow for focus to be appropriately shifted to dealing with the damaging structural problems within society.
A spokesperson for PHE said: The review was not able to look at genetic factors and more research in this area is needed.
To complement the review, a research call by the National Institute for Health Research (NIHR) and UK Research and Innovation (UKRI) has jointly called for research proposals to investigate emerging evidence of an association between ethnicity and COVID-19 incidence and adverse health outcomes.
Dr Morgan also queried how the report framed its discussion of the relationship between the BAME community and the NHS: The report missed a number of opportunities, such as not to consider that historical racism will impact on both the speed and level of treatment BAME groups are likely to receive when they interact with the NHS.
Instead, it focused on the fact that as a result of historical racism BAME groups are less likely to seek care when needed.
Both arguments are underpinned by historical racism, and should have been given equal weight in the report: By omitting the former it has the feel of blaming the victims for not complaining.
PHE conceded that the report did not consider every issue: There are many impacts of systemic racism and PHEs qualitative report identified the issues that were raised repeatedly by stakeholders.
This does not mean that other factors are not relevant and confirms the need for further more detailed research studies on these issues.
Dr Morgan concluded that despite reservations over the lack of wider recommendation about tackling structural racism in wider society, all seven recommendations should be implemented.
If you value what this story gives you, please consider supporting the Newham Recorder. Click the link in the orange box below for details.
The competition prevailing in theglobal biochemical sensor marketis considerably high. As leading companies fight out for the lead in the market, product innovations and launches are on cards. Besides this, investments in research and development have scaled higher as market players aim for emerging at the fore. In order to boost operations, several players are concentrating on expanding their regional footprint, especially in Asia Pacific. Cheap labor, abundance of raw materials, and the rising demand from emerging nations make the region highly lucrative for investment, finds Trends market research(TMR) in a Recent study.
Request For Report[emailprotected]https://www.trendsmarketresearch.com/report/sample/3433
Some of the most prominent names in the global biochemical sensor market are GE Healthcare, Thermo Fisher Scientific, Honeywell International, Inc., Bio-Rad Laboratories, Inc., and Polestar Technologies, Inc., among others. Besides aforementioned strategies, many of the market players are also pushing mergers and acquisitions to capitalize on their expertise and expand their product portfolio.
Overall, the global biochemical sensor market will rise at a healthy CAGR of XX% by 2025. At this pace, the market is expected to reach US$XX bn by the end of 2025, from its valuation of US$XX bn in 2016. Based on product, electrochemical sensors constituted the leading segment with a share of XX% in 2016. Besides this, piezoelectric sensor, thermal sensor, gas sensor, and optical sensor make other key segments in terms of product.
Regionally, North America held dominant with a share of over XX% in the global market in 2018. Europe and Asia Pacific followed closely as the second- and third-leading markets for biochemical in the same year. However, over the course of the forecast period, North America is likely to lose its market share, while Asia Pacific and Europe markets will witness accelerated pace of gains.
Application across Diverse Industries, Especially Healthcare, to Boost Growth
As biochemical sensors have found a leading end user in the healthcare sector, growth witnessed in the industry will subsequently fuel their demand. The healthcare infrastructure is a major consideration by governments when planning economic growth. Over the years, the industry has expanded exponentially. Additionally, investments in research and development are forecast to increase in the coming years. Biochemical sensors are used in the qualitative and quantitative assessment of clinical diagnosis in the healthcare sector, said a lead TMR analyst. The increasing aging population, coupled with the rising incidence of chronic ailments, will fuel the demand for precise diagnosis, thus providing significant impetus to the biochemical sensor market, he added.
Besides this, government initiatives to ensure superior food quality, advancements in material chemistry and wireless networks, the rising demand for advanced wearable biochemical sensors, and the growing population of point of care diagnostics will create lucrative market opportunities. RRI also prophesized that the rising oil extraction worldwide will tip scales in favor of the market. Rise in oil extraction would result in greater percentage of inflammable and toxic in the air. Spurred by this, the use of biochemical sensors will increase to detect the presence of toxic gas.
Get COVID-19 Report[emailprotected]https://www.trendsmarketresearch.com/report/covid-19-analysis/3433
Originally posted here:
Biochemical Sensor Market Sales, Consumption, Demand and Forecast 2018-2025 - Cole of Duty
Biochemical Sensor Market Will Grow at CAGR During 2019-2025 Global Evaluation by Trends, Proportions, Share, Swot, and Key Developments – Cole of…
A new research study has been presented by UpMarketResearch.com offering a comprehensive analysis on the Global Biochemical Sensor Market where user can benefit from the complete market research report with all the required useful information about this market. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought along several changes in market conditions. The rapidly changing market scenario and initial and future assessment of the impact is covered in the report. The report discusses all major market aspects with expert opinion on current market status along with historic data. This market report is a detailed study on the growth, investment opportunities, market statistics, growing competition analysis, major key players, industry facts, important figures, sales, prices, revenues, gross margins, market shares, business strategies, top regions, demand, and developments.
The Biochemical Sensor Market report provides a detailed analysis of the global market size, regional and country-level market size, segment growth, market share, competitive landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunity analysis, strategic market growth analysis, product launches, and technological innovations.
Get a Free Sample Copy of the Biochemical Sensor Market Report with Latest Industry Trends @ https://www.upmarketresearch.com/home/requested_sample/87715
Major Players Covered in this Report are: company 1company 2company 3company 4company 5company 6company 7company 8company 9
Global Biochemical Sensor Market SegmentationThis market has been divided into Types, Applications, and Regions. The growth of each segment provides an accurate calculation and forecast of sales by Types and Applications, in terms of volume and value for the period between 2020 and 2026. This analysis can help you expand your business by targeting qualified niche markets. Market share data is available on the global and regional level. Regions covered in the report are North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America. Research analysts understand the competitive strengths and provide competitive analysis for each competitor separately.
By Types:Type 1Type 2Type 3
By Applications:Application 1Application 2Application 3
To get Incredible Discounts on this Premium Report, Click Here @ https://www.upmarketresearch.com/home/request_for_discount/87715
Global Biochemical Sensor Market Regions and Countries Level AnalysisRegional analysis is a highly comprehensive part of this report. This segmentation sheds light on the sales of the Biochemical Sensor on regional- and country-level. This data provides a detailed and accurate country-wise volume analysis and region-wise market size analysis of the global market.
The report offers an in-depth assessment of the growth and other aspects of the market in key countries including the US, Canada, Mexico, Germany, France, the UK, Russia, Italy, China, Japan, South Korea, India, Australia, Brazil, and Saudi Arabia. The competitive landscape chapter of the global market report provides key information about market players such as company overview, total revenue (financials), market potential, global presence, Biochemical Sensor sales and revenue generated, market share, prices, production sites and facilities, products offered, and strategies adopted. This study provides Biochemical Sensor sales, revenue, and market share for each player covered in this report for a period between 2016 and 2020.
Make an Inquiry of this Report @ https://www.upmarketresearch.com/home/enquiry_before_buying/87715
Why Choose Us:
Table of Contents1. Executive Summary2. Assumptions and Acronyms Used3. Research Methodology4. Market Overview5. Global Market Analysis and Forecast, by Types6. Global Market Analysis and Forecast, by Applications7. Global Market Analysis and Forecast, by Regions8. North America Market Analysis and Forecast9. Latin America Market Analysis and Forecast10. Europe Market Analysis and Forecast11. Asia Pacific Market Analysis and Forecast12. Middle East & Africa Market Analysis and Forecast13. Competition Landscape
About UpMarketResearch:Up Market Research (https://www.upmarketresearch.com) is a leading distributor of market research report with more than 800+ global clients. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.
Contact Info UpMarketResearchName Alex MathewsEmail [emailprotected]Organization UpMarketResearchAddress 500 East E Street, Ontario, CA 91764, United States.
Daba Abdissa,1 Kumsa Kene2
1Department of Biomedical Sciences Division of Clinical Anatomy, College of Medical Sciences, Institute of Health Sciences, Jimma University, Jimma, Ethiopia; 2Department of Biomedical Sciences Division of Medical Biochemistry, College of Medical Sciences, Institute of Health Sciences, Jimma University, Jimma, Ethiopia
Correspondence: Daba Abdissa Tel +251 923503701Email firstname.lastname@example.org
Purpose: Hypertension is a growing public health problem with a remarkable contribution to morbidity and mortality. It is a common condition which usually coexists with diabetes and aggravates its complications. The objective of this study was to assess the prevalence and determinants of hypertension among diabetic patients attending their follow-up at Jimma University Medical Center (JUMC) from June 1 to August 30, 2019.Methods: A hospital-based cross-sectional study was conducted in diabetic patients attending their follow-up at JUMC. Systematic random sampling and a pretested interviewer-administered structured questionnaire were used to collect information. Data were entered into EPI data 3.1 and exported to SPSS version 20. A variable having a p-value of < 0.25 in the bivariate model was subjected to multivariate analysis to avoid the confounding variables effect. Adjusted odds ratios were calculated at the 95% confidence interval and considered significant with a p-value of < 0.05.Results: A total of 366 diabetic patients were included in the study. Their mean age was 50.1 14.28 years, and the mean duration of diabetes was 6.8 5.3 years. The study finding showed that the prevalence of hypertension among diabetic patients was 37.4%. According to the multivariate logistic regression analysis, age of 50 years [AOR = 4.79; 95% CI: 1.4, 16.4], having body mass index (BMI) of 25 [AOR = 3.11; 95% CI: 1.58, 6.12] and khat chewing [AOR =19.34; 95% CI: 10.26, 36.44] were independent predictors of hypertension among diabetic patients.Conclusion: Our study found that there is high prevalence of hypertension among diabetic patients. Age of 50 years, having BMI of 25 kg/m2 and khat chewing were associated with hypertension among participants. Early detection and appropriate interventions should be an important action among patients with age 50 years, having BMI 25kg/m2 and khat chewers.
Keywords: prevalence, determinants, hypertension, diabetes, Southwest Ethiopia
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
Go here to read the rest:
Prevalence and Determinants of Hypertension Among Diabetic Patients in | DMSO - Dove Medical Press